NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

OUR TEAM

Sector-specialist senior management team with extensive commercial experience.

  • John Clarkson

    John Clarkson, Non-Executive Chairman of the Group, is an experienced business professional and qualified accountant, who had a successful early career working in various …

    Non-Executive Chairman
  • Dr Ilian Iliev

    Dr. Ilian Iliev, Chief Executive Officer, is Managing Director of EMV Capital, a London-based investor in B2B companies in the industrial high-tech, energy, circular …

    Chief Executive Officer

NEWS

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Reports Financial Results for the …

NetScientific plc (“NetScientific” or the “Company”) Confirmation of Board Changes London, UK – 1 May 2020 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, confirms …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product     London, UK – 30 April …

NetScientific healthcare technology group